An economic evaluation of palliation of dysphagia in esophageal cancer: Analysis of the TROG 03.01/NCIC ES.2 phase III study in advanced esophageal cancer in patients treated with radiotherapy versus chemoradiotherapy.

Authors

Michael Gordon Penniment

Royal Adelaide Department of Radiation Oncology, Kensington Park, SA, Australia

Michael Gordon Penniment , Paolo De Ieso , Rebecca Wong , Hossein Afzali

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Sign-In

Similar Posters

insert_chart_outlined

Poster

2020 ASCO Virtual Scientific Program

bookmark_border

Radiotherapy after esophageal cancer stenting (ROCS): A pragmatic randomized controlled trial evaluating the role of palliative radiotherapy in maintaining swallow.

First Author: Anthony Thomas Byrne

insert_chart_outlined

Poster

2017 Genitourinary Cancers Symposium

bookmark_border

BC2001 long-term outcomes: A phase III randomized trial of chemoradiotherapy versus radiotherapy (RT) alone and standard RT versus reduced high-dose volume RT in muscle-invasive bladder cancer.

First Author: Emma Hall

insert_chart_outlined

Poster

2015 Gastrointestinal Cancers Symposium

bookmark_border

Full report of the TROG 03.01, NCIC CTG ES2 multinational phase III study in advanced esophageal cancer comparing palliation of dysphagia and quality of life in patients treated with radiotherapy or chemoradiotherapy.

First Author: Michael Gordon Penniment

insert_chart_outlined

Poster

2014 ASCO Annual Meeting

bookmark_border

A randomized phase III study in advanced esophageal cancer (OC) to compare the quality of life (QoL) and palliation of dysphagia in patients treated with radiotherapy (RT) or chemoradiotherapy (CRT) TROG 03.01 NCIC CTG ES.2.

First Author: Michael Gordon Penniment